CD44v6 and Nm23-Hl protein expression related to clinico pathological parameters in colorectal cancer

Annali Italiani di Chirurgia

Volumn 74, Issue 1, 2003, Pages 45-51

  Messinetti, S ^a   Giacomelli, L ^a   Fabrizio, G ^a   Giarnieri, E ^a   Gabatel, R ^a   Manno, A ^a   Feroci, D ^a   Guerriero, G ^a   Masci, E ^a   Vecchione, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Immunonistochemistry; Metastasis; Prognostic variables

Indexed keywords

CD44V6 ANTIGEN; GLYCOPROTEIN; HERMES ANTIGEN; MONOCLONAL ANTIBODY; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; TRANSCRIPTION FACTOR;

AGED; ARTICLE; CANCER STAGING; CARCINOMA; COLORECTAL TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM STAGING; NUCLEOSIDE-DIPHOSPHATE KINASE; TRANSCRIPTION FACTORS;

EID: 0142090474     PISSN: 0003469X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Steeg P.S., Bevilacqua G., Kopper L., et al.: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst, 80: 200-204, 1988.
2. Stahl J.A., Leone A., Rosengard A.M., Proter L., et al.: Identification of a second Nm23 gene, Nm23-H2. Cancer Res, 51: 445-449, 1991.
3. Cheah P.Y., Cao X., Eu K.W., et al.: Nm23-Hl immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas. Br J Cancer, 77 (7): 1164-1168, 1998.
4. Tabuchi Y., Nakamura T., Kuniyasu T., et al.: Expression of nm23-Hl in colorectal cancer: no association with metastases, histological stage, or survival. Jpn J Surg, 29: 116-120, 1999.
5. Nakayama H., Yasui W., Yokozaki H., et al.: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res, 84: 184-190, 1993.
6. Gunthert U., Hofmann M., Rudy W., et al.: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
7. Aruffo A., Stamenkovic I., Melnick M, et al.: CD44 is the principal cell surface receptor for hyaluronate. Cell, 1: 1303-1313, 1990.
8. Cooper D.L., Dougherty G., Harn HJ., et al: The complex CD44 transcriptional unit: alternative slicing of three internal exons generates the epithelial form of CD 44. Biochem Biophys Res Commum, 182: 569-578, 1992.
9. Papadogiannakis N., Gad A., Chenard M, et al.: Expression of CD44 variants in differential of ulcerative colitis and Crohn's disease. Lancet, 347: 1413-1414, 1996.
10. Heider K., Dammrich J., Skroch-Angel P., et al.: Differential expresion of CD44 splice variants in intestinal and diffuse type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993; 53: 4197-4207
11. Hase K., Shatney C, Johnson D., et al.: Prognostic value of tumour "budding" in patients with colorectal cancer. Dis Colon Rectum 1993; 36: 627-635
12. Berney CR., Yang J.L., Fisher R.J., Russel P.J., et al.: Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival. World J Surg, 22: 484-490, 1998.
13. Urano T., Furukawa K., Shiku H.: Expression of nm23/NDP kinase proteins on the cell surface. Oncogene, 8: 1371, 1993.
14. Howlett A.R., Petersen O.W., Steeg P.S., et al.: A novel function for the nm23-Hl gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst, 86: 1838, 1994.
15. Martinez J.A., Prevot S., Nordlinger B., Nguyuen T.M.A., et al.: Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumor stages. Gut, 37: 712-20, 1995.
16. Zeng Z.S., Hsu S., Zhang Z.F., et al.: High level of nm23-Hl gene expression is associated with local colorectal cancer progression not with metastases. Br J Cancer, 70: 1025-1030, 1994.
17. Giarnieri E., Alderisio M., Valu C, et al.: Overexpression of Ndp kinase nm23 associated withploidy image analysis in colorectal cancer. Anticancer Res, 15: 2049-2054, 1995.
18. Indinnimeo M., Giarnieri E., Stazi A., et al.: Early stage human colorectal cancer: prognostic value of nm23-Hl protein overexpression. Cancer Letters, 111: 1-5, 1997.
19. Berney CR., Fisher R.J., Yang J.L., et al.: Protein markers in colorectal cancer. Predictors of liver metastasis. Ann Surg, 230: 179-184, 1999.
20. Tabuchi Y., Nakamura T., Kuniyasu, et al.: Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival. Jpn J Surg, 29: 116-120, 1999.
21. Mueller J.D., Heider K.H., Oberhuber G., et al.: Comparison of Cd44 expression in early colorectal carcinomas of the de novo and ex adenoma types. Virchows Arch, 433: 407-414, 1998.
22. Neumayer R., Rosen H.R., Reiner A., et al.: CD44 expression in benign and malignant colorectal polyps. Dis Colon Rectum, 42: 50-55, 1999.
23. Coppola D., Hyacinthe M., Fu I., et al.: CD44v6 expression in human colorectal carcinoma. Hum Pathol, 29(6): 627-635, 1998.
24. Herrlich P., Zoller M., Pals ST, et al.: CD44 splice variants: metastases meet lymphocytes. Immunol Today, 14: 395-399, 1993.
25. Wielenga V.J., Heider K.H., Offerhaus J.A., et al.: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res, 53: 4754-6, 1993.
26. Mulder J.W., Wielenga V.J., Polak M.M., et al.: Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut, 36: 76-80, 1995.
27. Mulder J.W., Kruyt P.M., Sewnath M., et al.: Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 344: 1470-2, 1994.
28. Givehchian M., Worner S., Strater J, et al.: No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer. Eur J Cancer, 34(7): 1099-1104, 1998.
29. Weg-Remers S., Anders M., von Lampe B., et al.: Decreased expression of CD44v6 splicing variants in advanced colorectal carcinomas. Eur J Cancer, 34(10): 1607-1611, 1998.
30. Ishida T.: Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma. Jpn J Surg, 30: 28-32, 2000.